Abbott Labs Financial Statements
Abbott Labs Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Abbott Labs Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 25,914.2 | 22,476.3 | 22,337.8 |
| Gross Profit ($ mil.) | 14,492.2 | 12,661.2 | 11,696.7 |
| Operating Income ($ mil.) | 4,578.5 | 2,042.2 | 4,362.3 |
| Total Net Income ($ mil.) | 3,606.3 | 1,716.8 | 3,372.1 |
| Diluted EPS (Net Income) | 2.31 | 1.12 | 2.16 |
Abbott Labs Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 7,314.0 | 6,765.6 | 7,221.4 |
| Gross Profit ($ mil.) | 4,194.3 | 3,804.5 | 4,059.7 |
| Operating Income ($ mil.) | 1,406.6 | 1,147.8 | 1,518.0 |
| Total Net Income ($ mil.) | 1,322.0 | 937.9 | 1,203.0 |
| Diluted EPS (Net Income) | 0.85 | 0.60 | 0.77 |
Abbott Labs Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 3.29 | 3.32 | 1.48 |
| Price/Earnings Ratio | 21.72 | 14.77 | 15.35 |
| Price/Book Ratio | 4.80 | 2.73 | 1.44 |
| Price/Cash Flow Ratio | 16.12 | 12.22 | 9.34 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Abbott Labs Financial Ratios
Abbott Labs Competitive Intelligence
| Merck | Roche | Sanofi-Aventis | |
|---|---|---|---|
| Annual Sales ($ mil.) | 24,197.7 | 34,465.2 | 43,019.0 |
| Employees | 59,800 | 74,372 | 99,495 |
| Market Cap ($ mil.) | 72,458.5 | -- | -- |
Competitive Landscape
